Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Inhibitors of protein kinase GSK3 prepared at Chiron, U. of California

July 8, 1998

Phase Ia clinical trial with NIF for ischemic stroke completed by Pfizer

July 7, 1998

CNS-selective effects of synthetic, nonfeminizing estrogens

July 7, 1998

New antimigraine option now available in Canada

July 7, 1998

Ganaxolone study results presented at AASH meeting

July 7, 1998

Taisho claims potent and selective D4 receptor antagonists

July 7, 1998

OPC-14117: tolerability and safety as antioxidant therapy for Huntington's disease

July 7, 1998

S-8510 enhances cognition and acetylcholine release in basal forebrain-lesioned rats

July 6, 1998

CNI-1493 treatment associated with improvement in mouse model of MS

July 6, 1998

Nihon Nohyaku claims arylpiperidines for schizophrenia, dementia

July 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...